| III-79 Hinke Siebinga Optimizing radionuclide therapy with 177Lu-HA-DOTATATE in patients with neuroendocrine tumors using semi-physiological population PK models Thursday 10:15-11:45 |
| III-79 Hinke Siebinga Optimizing radionuclide therapy with 177Lu-HA-DOTATATE in patients with neuroendocrine tumors using semi-physiological population PK models Thursday 10:15-11:45 |